Augmentation therapy can save lives of people with alpha-1 antitrypsin deficiency, study shows

Boosting levels of a deficient protein has clear survival benefits for people with the genetic condition alpha-1 antitrypsin deficiency (AATD), according to new research led by RCSI University of Medicine and Health Sciences.

Related Keywords

Switzerland ,Austria ,Ireland ,United States ,American ,Irish ,Daniel Fraughen ,Gerry Mcelvaney ,Geraldine Kelly ,Lily Ramsey ,Irish Centre For Genetic Lung Disease ,Health Sciences ,University Of Medicine ,Foundation Ireland ,Department Of Medicine ,American Journal ,Critical Care Medicine ,Irish Centre ,Genetic Lung Disease ,Senior Lecturer ,Chief Scientist ,Professor Gerry Mcelvaney ,Genetic ,Alpha 1 Antitrypsin Deficiency ,Critical Care ,Emphysema ,Liver ,Liver Disease ,Ung Disease ,Medicine ,Protein ,Research ,Espiratory ,